Anthropic PBC, the largest IPO in history, began trading today as the artificial intelligence lab entered the AI marketplace to compete mainly with OpenAI and Google.
On opening day, the Anthropic IPO (NASDAQ: ANT) was oversubscribed, and only 15% of the offering was allocated to retail investors, according to Yahoo Finance.
Shares rose over their IPO price after the artificial intelligence lab’s $107.3 billion valuation exceeded SpaceX’s record for the biggest-ever offering, according to Bloomberg.
On its first day as a public company, Anthropic had a fully diluted market value of about $1.8 trillion. This ranked it among the 10 biggest public companies globally by market cap, rivaling SpaceX and briefly challenging Amazon.com Inc.
In this competitive, capital-intensive industry, Anthropic’s main competitors are OpenAI and Google, along with major tech players and specialized AI labs such as xAI, Amazon, Microsoft, Meta, Mistral AI, and Cohere, according to Forbes.
But for retail investors, what is Anthropic, what are its market advantages and risks, and how can retail investors take advantage of Anthropic’s expertise?
To get these answers, The Progressive Investor asked Paul Marino, CRO
of Themes ETF, based in Greenwich, Connecticut, about Anthropic and its future investment potential. Themes ETF offers three daily leveraged and inverse ETFs designed to track Anthropic stock. They are: ANUU (2x long Anthropic stock); ANDD (2x short Anthropic stock); and ANSS (1x short Anthropic stock).
The Progressive Investor (PI): Some people think Anthropic’s Claude AI will be embedded in coding, regulated industries, and enterprise systems. How will Anthropic profit from those relationships?
Marino: Anthropic accrues profits via high-margin usage-based API fees and enterprise seat subscriptions. Embedding Claude into mission-critical coding and compliance workflows creates high switching costs, encouraging its customers to steadily upgrade to costlier, higher-volume tiers.
PI: There could be a price war between Anthropic, Google, and OpenAI on a cost-per-task basis. How will that affect the price of Anthropic shares in the near and long term?
Marino: In the near term, a price war with Google and OpenAI compresses gross margins and introduces share volatility as investors scrutinize unit economics. Anthropic’s share price will ultimately depend on whether surging enterprise token volume outpaces per-unit price compression.
PI: What is Anthropic’s long-term position in high-value use situations?
Marino: Anthropic holds a strong defensive moat in complex reasoning, software engineering, and safety-sensitive domains like finance, healthcare, and law. Given enterprise emphasis on reliability, auditability, and low hallucination rates over just costs, Anthropic’s safety-first architecture positions it to capture premium enterprise share.
PI: Anthropic is being launched at the end of the year, which is a traditionally slow time in the markets. How many quarters out do you expect the initial excitement around the Anthropic IPO to reach equilibrium?
Despite launching during a seasonally quiet late-year window, institutional demand for a premier AI pure-play is massive.
Initial trading volatility will likely settle into a fundamental equilibrium within two to three quarters - by which time post-IPO lockup expirations will have cleared, and the market will have multiple quarterly earnings cycles to verify whether Anthropic’s 40%–60% projected revenue growth holds versus compute spend.
PI: How will Anthropic's price be affected if AI price appreciation slows down, or more federal regulation is enacted on the construction of data centers in the US?
Marino: Given its 30x+ forward revenue valuation, a slowdown in AI valuation multiples would trigger sharp multiple compression for Anthropic. Meanwhile, stricter federal permitting, environmental rules on U.S. data centers, et al. would create severe supply bottlenecks, drive up compute costs, and squeeze margins hard.
PI: Are you concerned about the debt-fueled AI investment boom in the US?
Marino: Yes, the circular, debt-heavy financing across the AI stack warrants substantial caution. Hyperscalers are financing massive data center buildouts while lending capital to AI labs that immediately spend it back on compute. If ROI lags behind infrastructure depreciation schedules, credit markets will tighten, borrowing costs will rise, and the sector will face painful capex cutbacks.
PI: Anthropic is organized as a Public Benefit Corporation. Does that structure affect its long-term growth prospects?
Marino: Anthropic's charter - which legally obligates the board to balance shareholder returns with AI safety and societal benefit - is designed to build trust with Fortune 500 buyers and regulators. However, the language is cloudy: how does one define benefit or safety? Doesn't this change depending on who's asking and answering?
On paper, this will restrict its accessible market. In reality, this might just be an image-building exercise.
PI: Anthropic’s IPO filing has about 100 pages of risk factors. How does that affect your research opinion?
Marino: Extensive risk disclosures are standard legal insulation for a frontier technology IPO. The hazards mentioned - existential safety liabilities, a massive dependence on rival cloud providers, and unprecedented off-balance-sheet compute obligations - underscore that Anthropic carries execution risks far higher than traditional enterprise software peers.
PI: Anthropic has about $900 billion in future liabilities and has never made a profit. How does that affect the company’s future profitability and growth rate?
Marino: While Anthropic achieved roughly 85% gross margins before model-training R&D, heavy ongoing training expenses pushed Q3 2026 operating margins to -3%. Future profitability hinges entirely on keeping revenue growth ahead of rigid, take-or-pay infrastructure bills. With model parity with its rivals and deep-pocketed conglomerates like Google closing in, the company's outlook will be under pressure for years to come.
PI: What is token maxing, and how does that affect Anthropic's valuation?
Marino: Token maxing refers to artificially inflating AI token consumption without generating proportional business value. While high token volume boosts Anthropic’s near-term top-line revenue, over-reliance on unoptimized usage threatens its long-term valuation if enterprises deploy governance tools to slash wasted API spend.
PI: Are you worried about Anthropic's limited number of big customers, aka, its concentration risk?
Marino: While direct customer concentration is improving rapidly with revenue outside Anthropic’s top five clients rising to 79% in Q3 2026 and no single buyer exceeding 10%, distribution concentration remains a major vulnerability: 44% of revenue flows through AWS, Google Cloud, and Microsoft — firms that are simultaneously Anthropic’s largest investors, compute suppliers, and fiercest AI rivals. There is no clear way for Anthropic to reduce this risk. This is both a matter of concern and a form of valuation support for the likes of Amazon, Google and Microsoft: if Anthropic does well, they could do much better.
How Retail Investors Can Invest in Anthropic
Currently, there is no dedicated single-stock Anthropic ETF trading. However, several ETFs already hold pre-IPO exposure to Anthropic, and multiple single-stock leveraged/inverse funds are now open for trading.
Other ETFs With Existing Anthropic Exposure
Tema Photonics & Optical ETF (LAZR): Holds roughly 10% to 12% in Anthropic.
KraneShares Public-Private AI & Technology ETF (AGIX): Allocates roughly 1% to 3% to Anthropic alongside other public and private AI names.
Other Active and Swap-Based ETFs: Funds such as the iShares A.I. Innovation and Tech Active ETF (BAI), Alger 35 ETF (ATFV), and select swap-based funds also carry exposure.

Comments